290 related articles for article (PubMed ID: 35283385)
21. Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Merkel M; Danese D; Chen C; Wang J; Wu A; Yang H; Lin H
Expert Opin Pharmacother; 2023; 24(10):1205-1214. PubMed ID: 37219406
[TBL] [Abstract][Full Text] [Related]
22. Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan.
Matsushima M; Tarisawa M; Nomura T; Oshima Y; Yoshino M; Shibata Y; Wakita M; Shirai S; Iwata I; Yaguchi H; Yabe I
Intern Med; 2023 Jun; 62(11):1599-1602. PubMed ID: 36261369
[TBL] [Abstract][Full Text] [Related]
23. Rare c.302C>T
Žebrauskienė D; Sadauskienė E; Masiulienė R; Aidietienė S; Šiaudinienė A; Pečeliūnas V; Žukauskaitė G; Žurauskas E; Valevičienė N; Barysienė J; Preikšaitienė E
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399526
[No Abstract] [Full Text] [Related]
24. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H
Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540
[TBL] [Abstract][Full Text] [Related]
25. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
Caponetti AG; Rapezzi C; Gagliardi C; Milandri A; Dispenzieri A; Kristen AV; Wixner J; Maurer MS; Garcia-Pavia P; Tournev I; Planté-Bordeneuve V; Chapman D; Amass L;
JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
[TBL] [Abstract][Full Text] [Related]
26. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
27. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
[No Abstract] [Full Text] [Related]
28. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U
Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.
Monteiro C; Martins da Silva A; Ferreira N; Mesgarzadeh J; Novais M; Coelho T; Kelly JW
Amyloid; 2018 Jun; 25(2):120-128. PubMed ID: 29993288
[TBL] [Abstract][Full Text] [Related]
30. [Liver transplantation for familial amyloid polyneuropathy].
Adams D; Slama M; Samuel D
Presse Med; 2010 Jan; 39(1):17-25. PubMed ID: 19419835
[TBL] [Abstract][Full Text] [Related]
31. Hereditary transthyretin amyloidosis overview.
Manganelli F; Fabrizi GM; Luigetti M; Mandich P; Mazzeo A; Pareyson D
Neurol Sci; 2022 Dec; 43(Suppl 2):595-604. PubMed ID: 33188616
[TBL] [Abstract][Full Text] [Related]
32. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
[TBL] [Abstract][Full Text] [Related]
34. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology.
Sekijima Y; Hammarström P; Matsumura M; Shimizu Y; Iwata M; Tokuda T; Ikeda S; Kelly JW
Lab Invest; 2003 Mar; 83(3):409-17. PubMed ID: 12649341
[TBL] [Abstract][Full Text] [Related]
35. Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid.
Tsai FJ; Jaeger M; Coelho T; Powers ET; Kelly JW
Amyloid; 2023 Sep; 30(3):279-289. PubMed ID: 36691999
[TBL] [Abstract][Full Text] [Related]
36. Symptomatic Val122del mutated hereditary transthyretin amyloidosis: Need for early diagnosis and prioritization for heart and liver transplantation.
Schettini AV; Llado L; Heimbach JK; Costello JG; Tranäng M; Van Caenegem O; Daly RC; Van den Bergh P; Casanovas C; Fabregat J; Poterucha JJ; Foguenne M; Ericzon BG; Lerut J
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):323-329. PubMed ID: 34116942
[TBL] [Abstract][Full Text] [Related]
37. Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.
Finsterer J; Wanschitz J; Quasthoff S; Iglseder S; Löscher W; Grisold W
Acta Neurol Scand; 2017 Dec; 136(6):558-569. PubMed ID: 28295152
[TBL] [Abstract][Full Text] [Related]
38. Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy.
Tozza S; Palumbo G; Severi D; Iovino A; Spina E; Aruta F; Cassano E; Iodice R; Dubbioso R; Ruggiero L; Nolano M; Santoro L; Manganelli F
Neurol Sci; 2024 Apr; 45(4):1685-1689. PubMed ID: 37870643
[TBL] [Abstract][Full Text] [Related]
39. Liver transplantation in transthyretin amyloidosis: issues and challenges.
Carvalho A; Rocha A; Lobato L
Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
[TBL] [Abstract][Full Text] [Related]
40. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report.
Thimm A; Oubari S; Hoffmann J; Carpinteiro A; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Röcken C; Diebold I; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
BMC Neurol; 2022 Dec; 22(1):469. PubMed ID: 36494773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
